Podcasts about paradigms

The Unseen Force That Controls 95% of Your Life   This episode of the Rich Mind Podcast is a deep dive into one of the most powerful and invisible forces shaping our lives: our paradigms. Inspired by the teachings of the late Bob Proctor, Randy and his daughter Adrienne discuss how these deep-seated mental programs, or "software," installed in us since childhood, control our thoughts, feelings, and actions. They explore how our paradigms act as a filter, often creating self-imposed limitations and keeping us stuck. The conversation provides practical insights into how to become aware of your own paradigm, how to challenge the "black and white" thinking it creates, and why understanding this concept is the key to creating a life of your own design, rather than one dictated by old programming.   Key Takeaways:   A paradigm is like the software that runs your life; it's a collection of habits and beliefs programmed into your subconscious mind from a young age. Most of our struggles in finances, relationships, and health are not due to external factors, but are results generated by our internal paradigm. Society often teaches us in absolutes ("right vs. wrong," "good vs. bad"), which reinforces a rigid paradigm and makes it difficult to see the "gray" areas of life. Our triggers are often the paradigm's defense mechanism, activating past beliefs ("I'm not smart enough," "I'm not good enough") to keep us in our comfort zone. You can begin to change your paradigm by questioning your automatic thoughts and separating your identity from your feelings (e.g., saying "I am feeling frustrated" instead of "I am frustrated"). The phrase "What's meant for me will find me, and anything else is none of my business" is a powerful tool to release the need for external validation and stay focused on your own path. Consistent practices like journaling or recording voice memos are crucial tools for getting your subconscious thoughts out, observing them objectively, and identifying the patterns of your paradigm.   Questions Answered in This Episode:   What is a paradigm and how does it control your life? How are our paradigms formed in childhood? How does your paradigm keep you from seeing opportunities and achieving your goals? What does it mean to break free from "black and white" thinking? How are our emotional triggers connected to our deep-seated paradigms? What are "I am" statements and how can they reinforce or change your paradigm? How can you stop caring about what other people think of you? What are practical, daily actions you can take to become aware of and start changing your paradigm?   Key People, Concepts, & Terms:   People: Randy Wilson, Adrienne Wilson, Bob Proctor, David Neagle. Concepts: Paradigm, Subconscious Mind, Software/Hardware Analogy, Triggers, Filtering System, Black and White Thinking, I Am Statements, Personal Development, Journaling.   Key Episode Timestamps   00:00 - Introduction: Unpacking the Power of Paradigms with Bob Proctor 03:56 - Defining a Paradigm: It's a Filtering System That Creates "Black and White" Thinking 05:37 - Challenging the Paradigm: Realizing Life Isn't "Right vs. Wrong" 08:00 - How Paradigms Create Limiting Beliefs ("I'm Not Smart Enough") 10:55 - Key Insight: Our Paradigms Activate Our "Triggers" 13:17 - A Powerful Mantra: "What's Meant for Me Will Find Me, and Anything Else is None of My Business" 22:40 - How to Recognize Your Triggers in Real-Time 23:14 - Actionable Technique: Separating Your Feelings from Your Identity ("I am feeling..." vs. "I am...") 30:43 - The Power of One Step Forward: Progress Over Perfection 34:38 - Practical Tools: Journaling and Voice Memos to Uncover Your Paradigm

Dr Adam Koontz and Col Willie Grills talk about how different forms of media defined generational divides and how that affected the political landscape. Visit our website - A Brief History of Power Thanks to our sponsor, Gnesio Health Dr Adam Koontz - Redeemer Lutheran Church Pr. Willie Grills - Zion Lutheran Church Music thanks to Verny

Dr. Pedro Barata and Dr. Rana McKay discuss the integration of innovative advances in molecular imaging and therapeutics to personalize treatment for patients with renal cell and urothelial carcinomas. TRANSCRIPT Dr. Pedro Barata: Hello, I'm Dr. Pedro Barata, your guest host of By the Book, a podcast series featuring insightful conversations between authors and editors of the ASCO Educational Book. I'm a medical oncologist at University Hospitals Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I'm also an associate editor of the ASCO Educational Book. Now, we all know the field of genitourinary cancers (GU) is evolving quite rapidly, and we have new innovations in molecular imaging as well as targeted therapeutics. Today's episode will be exploring novel approaches that are transforming the management of renal cell and urothelial carcinomas and also their potential to offer a more personalized treatment to patients. For that, joining for today's discussion is Dr. Rana McKay, a GU medical oncologist and professor at University of California San Diego. Dr. McKay will discuss her recently published article titled, “Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor-Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and Urothelial Carcinomas.”  Our full disclosures are available in the transcript of this episode.  And with that, Rana McKay, great to have you on the podcast today. Dr. Rana McKay: Oh, thank you so much, Dr. Barata. It's really wonderful to be here with you. So, thanks for hosting. Dr. Pedro Barata: No, thanks for taking the time, and I'm looking forward to this conversation. And by the way, let me start by saying congrats on a great article in the Educational Book. Really super helpful paper. I'm recommending it to a lot of the residents and fellows at my own institution. I would like to first ask you to kind of give our listeners some context of how novel approaches in the molecular imaging as well as targeted therapeutics are actually changing the way we're managing patients with GU, but specifically with renal cell carcinoma and urothelial carcinoma. So, what are the areas you would call out as like being big areas for innovation in this context, and why are they important? Dr. Rana McKay: Very good question. And I think this is really what this article highlights. It highlights where are we going from an imaging diagnostics standpoint? Where are we going from a therapeutic standpoint? And I think if we have to step back, from the standpoint of diagnostics, we've seen PET imaging really transform diagnostics in prostate cancer with the advent of PSMA PET imaging, and now PSMA PET imaging is used as a biomarker for selection for theranostics therapy. And so, we're starting to see that enter into the RCC landscape, enter into the urothelial cancer landscape to a lesser extent. And I think it's going to potentially be transformative as these tools get more refined. I think when we think about therapeutics, what's been transformative most recently in the renal cell carcinoma landscape has been the advent of HIF2α inhibition to improve outcomes for patients. And we have seen the approval of belzutifan most recently that has reshaped the landscape. And now there's other HIF2α inhibitors that are being developed that are going to be further important as they get refined. And lastly, I think when we think about urothelial carcinoma, the greatest transformation to treatment in that context has been the displacement of cisplatin and platinum-based chemotherapy as a frontline standard with the combination of enfortumab vedotin plus pembrolizumab. And we've seen antibody-drug conjugates really reshape treatment and tremendously improve outcomes for patients. So, I think those are the three key areas of interest. Dr. Pedro Barata: So with that, let's focus first on the imaging and then we'll get to the therapeutic area. So, we know there's been a paradigm shift, really, when prostate-specific targets emerged as tracers for PET scanning. And so, we now commonly use prostate-specific membrane antigen, or PSMA-based PET scanning, and really transform how we manage prostate cancer. Now, it appears that we're kind of seeing a similar wave in renal cell carcinoma with the new radiotracer against the target carbonic anhydrase IX. What can you tell us about this? And is this going to be available to us anytime soon? And how do you think that might potentially change the way we're managing patients with RCC today? Dr. Rana McKay: First, I'll step back and say that in the context of PSMA PET imaging, we have actually been able to better understand RCC as well. So, we know that PSMA is expressed in the neovasculature of tumors, and it can actually be used to detect renal cell carcinoma tumors. It has a detection rate of about 84% when used for detection. And so, you know, I don't think it's just restricted to carbonic anhydrase IX, but we will talk about that. So, PSMA expressed in the neovasculature has a detection rate of around 84%, particularly if we're looking at clear cell RCC. CAlX is overexpressed in clear cell RCC, and it's actually used in diagnosing renal cell carcinoma when we think of CAlX IHC for diagnosing clear cell RCC. And now there are CAlX PET tracers. The first foray was with the ZIRCON study that was actually an interestingly designed study because it was designed to detect the likelihood of PET imaging to identify clear cell RCC. So, it was actually used in the early diagnostics setting when somebody presents with a renal mass to discriminate that renal mass from a clear cell versus a non-clear cell, and it was a positive study. But when I think about the potential application for these agents, you know, I think about the entire landscape of renal cell carcinoma. This is a disease that we do treat with metastasis-directed therapy. We have certainly seen patients who've undergone metastasectomy have long, durable remissions from such an approach. And I think if we can detect very early onset oligometastatic disease where a metastasis-directed therapy or SABR could be introduced - obviously tested in a trial to demonstrate its efficacy - I think it could potentially be transformative. Dr. Pedro Barata: Wonderful. It's a great summary, and I should highlight you are involved in some of those ongoing studies testing the performance of this specific PET scanning for RCC against conventional imaging, right? And to remind the listeners, thus far, for the most part, we don't really do FDG-PET for RCC. There are some specific cases we do, but in general, they're not a standard scanning. But maybe that will change in the future. Maybe RCC will have their own PSMA-PET. And to your point, there's also emerging data about the role of PSMA-PET scanning in RCC as well, as you very elegantly summarized. Wonderful. So, let me shift gears a little bit because you did, in your introduction, you did highlight a novel MOA that we have in renal cell carcinoma, approved for use, initially for VHL disease, and after that for sporadic clear cell renal cell carcinoma. We're talking about hypoxia-inducible factor 2-alpha inhibitors, or HIF2α inhibitors, such as belzutifan. But there's also others coming up. So, as a way to kind of summarize that, what can you tell us about this breakthrough in terms of therapeutic class, this MOA that got to our toolbox of options for patients with advanced RCC? Tell us a little bit what is being utilized currently in the management of advanced RCC. And where do you see the future going, as far as, is it moving early on? Is it getting monotherapy versus combinations? Maybe other therapies? What are your thoughts about that? What can you tell us about it? Dr. Rana McKay: Belzutifan is a first-in-class HIF2α inhibitor that really established clinical validation for HIF2α as a therapeutic target. When we think about the activity of this agent, the pivotal LITESPARK-005 trial really led to the approval of belzutifan in patients who were really heavily pretreated. It was patients who had received prior IO therapy, patients who had received prior VEGF-targeted therapy. And in the context of this study, we saw a median PFS of 5.6 months, and there did seem to be a tail on the curve when you looked at the 12-month PFS rate with belzutifan. It was 33.7% compared to 17.6% with everolimus. And then when we look at the response rate, it was higher with belzutifan on the order of 22-23%, and very low with everolimus, as we've previously seen. I think one of the Achilles heels of this regimen is the primary PD rate, which was 34% when used in later line. There are multiple studies that are testing belzutifan in combination across the treatment landscape. So, we have LITESPARK-011, which is looking at the combination of belzutifan plus lenvatinib in the second-line setting. We've got the MK-012 [LITESPARK-012] study, which is looking at belzutifan in various combinations in the frontline setting. So there is a combination with IO plus belzutifan. And so this is also being looked at in that context. And then we also have the LITESPARK-022 study, which is looking at pembrolizumab with belzutifan in the adjuvant setting. So there's a series of studies that will be exploring belzutifan really across the treatment landscape. Many of these studies in combination. Additionally, there are other HIF2α inhibitors that are being developed. We have casdatifan, which is another very potent HIF2α inhibitor. You know, I think pharmacologically, these are different agents. There's a different half-life, different dosing. What is going to be the recommended phase 3 dose for both agents, the EPO suppression levels, the degree of EPO suppression, and sustainability of EPO suppression is very different. So, I think we've seen data from casdatifan from the ARC-20 trial from monotherapy with a respectable response rate, over 30%, primary PD rate hovering just around 10%.  And then we've also seen data of the combination of casdatifan with cabozantinib as well that were recently presented this year. And that agent is also being tested across the spectrum of RCC. It's being looked at in combination with cabozantinib in the PEAK-1 study, and actually just at the KCRS (Kidney Cancer Research Summit), we saw the unveiling of the eVOLVE-RCC trial, which is going to be looking at a volrustomig, which is a PD-1/CTLA-4 inhibitor plus casdatifan compared to nivo-ipi in the frontline setting.  So, we're going to see some competition in this space of the HIF2α inhibitors. I think when we think of mechanism of action in that these are very potent, not a lot of off-target activity, and they target a driver mutation in the disease. And that driver mutation happens very early in the pathogenesis. These are going to be positioned much earlier in the treatment landscape. Dr. Pedro Barata: All these studies, as you're saying, look really promising. And when we talk about them, you mentioned a lot of combinations. And to me, when I think of these agents, it makes a lot of sense to combine because there's not a lot of overlapping toxicities, if you will. But perhaps for some of our listeners, who have not used HIF2α inhibitors in practice yet, and they might be thinking about that, what can you tell us about the safety profile? How do you present it to your patients, and how do you handle things like hypoxia or anemia? How do you walk through the safety profile and tolerability profile of those agents like belzutifan? Dr. Rana McKay: I think these drugs are very different than your traditional TKIs, and they don't cause the classic symptoms that are associated with traditional TKIs that many of us are very familiar with like the rash, hand-foot syndrome, hypertension, diarrhea. And honestly, these are very nuanced symptoms that patients really struggle with the chronicity of being on a chronic daily TKI. The three key side effects that I warn patients about with HIF2α inhibitors are: (1) fatigue; (2) anemia; and (3) hypoxia and dysregulation in the ability to sense oxygen levels. And so, many of these side effects - actually, all of them - are very dose-dependent. They can be very well-managed. So, we can start off with the anemia. I think it's critically important before you even start somebody on belzutifan that you are optimizing their hemoglobin and bone marrow function. Make sure they don't have an underlying iron deficiency anemia. Make sure they don't have B12 or folate deficiency. Check for these parameters. Many patients who have kidney cancer may have some hematuria, other things where there could be some low-level blood loss. So, make sure that those are resolved or you're at least addressing them and supplementing people appropriately. I monitor anemia very closely every 3 to 4 weeks, at least, when people start on these medications. And I do initiate EPO, erythropoietin, should the anemia start to worsen. And I typically use a threshold of around 10g/dL  for implementing utilization of an EPO agent, and that's been done very safely in the context of the early studies and phase 3 studies as well. Now, with regards to the hypoxia, I think it's also important to make sure that you're selecting the appropriate individual for this treatment. People who have underlying COPD, or even those individuals who have just a very high burden of disease in their lung, lymphangitic spread, pleural effusions, maybe they're already on oxygen - that's not an ideal candidate for belzutifan. Something that very easily can be done in the clinic before you think about initiating somebody on this treatment, and has certainly been integrated into some of the trials, is just a 6-minute walk test. You know, have the patient walk around the clinic with one of the MAs, one of the nurses, put the O2 sat on [measuring oxygen saturation], make sure they're doing okay. But these side effects, like I said, are very dose-dependent. Typically, if a patient requires, if the symptoms are severe, the therapy can be discontinued and dose reduced. The standing dose is 120 mg daily, and there's two dose reductions to 80 mg and 40 mg should somebody warrant that dose modification. Dr. Pedro Barata: This is relatively new, right? Like, it was not that we're used to checking oxygen levels, right? In general, we're treating these patients, so I certainly think there's a learning curve there, and some of the points that you highlight are truly critical. And I do share many of those as well in our practice. Since I have you, I want to make sure we touch base on antibody-drug conjugates as well. It's also been a hot area, a lot of developments there. When I think of urothelial carcinoma and renal cell carcinoma, I see it a little bit different. I think perhaps in urothelial carcinoma, antibody-drug conjugates, or ADCs, are somewhat established already. You already mentioned enfortumab vedotin. I might ask you to expand a little bit on that. And then in renal cell carcinoma, we have some ADCs as well that you include in your chapter, and that I would like you to tell us what's coming from that perspective. So, tell us a little bit about how do you see ADCs in general for GU tumors, particularly UC and RCC? Tell us a little bit about the complexity or perhaps the challenges you still see. At the same time, tell us about the successes. Dr. Rana McKay: Stepping back, let's just talk about like the principles and design of ADCs. So, most ADCs have three components. There's a monoclonal antibody that typically targets a cell surface antigen, which is conjugated by a linker, which is the second component, to a payload drug. And typically, that payload drug has been chemotherapy, whether it be topoisomerase or whether it be MMAE or other chemotherapeutic. We can start in the RCC space. There's been multiple antibody-drug conjugates that have been tested. There's antibody-drug conjugates to CD70, which is expressed on clear cell RCC. There's been antibody-drug conjugates to ENPP3, which is also expressed on RCC. There's antibody-drug conjugates to CDH6. And they have different payloads, like I said, whether it be topoisomerase I or other microtubule inhibitors. Now, when we think about kidney cancer, we don't treat this disease with chemotherapy. This disease is treated with immunotherapy. It is treated with treatments that target the VEGF pathway and historically has not been sensitive to chemo. So, I think even though the targets have been very exciting, we've seen very underwhelming data regarding activity, and in some context, seen increased toxicity with the ADCs. So, I think we need to tread lightly in the context of the integration and the testing of ADCs in RCC. We just came back from the KCRS meeting, and there was some very intriguing data about a c-Kit ADC that's being developed for chromophobe RCC, which is, you know, a huge unmet need, these variant tumors that really lack appropriate therapeutics. But I just caution us to tread lightly around how can we optimize the payload to make sure that the tumor that we're treating is actually sensitive to the agent that's targeting the cell kill. So, that's a little bit on the ADCs in RCC. I still think we have a long way to go and still in early testing. Now, ADCs for UC are now the standard of care. I think the prototypical agent, enfortumab vedotin, is a nectin-4-directed ADC that's conjugated to an MMAE payload and was the first ADC approved for advanced urothelial, received accelerated approval following the EV-201 trial, which was basically a multicenter, single-arm study that was investigating EV in cisplatin-ineligible patients with advanced urothelial carcinoma, and then ultimately confirmed in the EV-301 study as well. And so, that study ended up demonstrating the support superiority of EV from an overall survival standpoint, even PFS standpoint. Building on that backbone is the EV-302 study, which tested EV in combination with pembrolizumab versus platinum-based chemotherapy in the frontline setting. And that was a pivotal, landmark study that, like I said, has displaced platinum therapy as a frontline treatment for people with advanced urothelial carcinoma. And when we think about that study and the median overall survival and just how far we've come in urothelial cancer, the median OS with EV-pembro from that trial was 31 and a half months. I mean, that's just incredible. The control arm survival was 16 and a half months. The hazard ratio for OS, 0.47. I mean this is why when this data was presented, it was literally a standing ovation that lasted for several minutes because we just haven't seen data that have looked that good. And there are other antibody-drug conjugates that are being tested. We've all been involved in the saga with sacituzumab govitecan, which is a trophoblast cell surface antigen 2 (Trop-2) targeted ADC with a topoisomerase I payload. It was the second ADC to receive approval, but then that approval was subsequently withdrawn when the confirmatory phase 3 was negative, the TROPiCS-04 trial. So, approval was granted based off of the TROPHY-U-01, single-arm, phase 2 study, demonstrating a response rate of around 28% and a PFS of, you know, about 5 and a half months. But then failure to show any benefit from an OS standpoint. And I think there's a lot of controversy in the field around whether this agent still has a role in advanced urothelial carcinoma. And I think particularly for individuals who do not have molecular targets, like they're not HER2-amplified or have HER2-positivity or FGFR or other things like that. Dr. Pedro Barata: Fantastic summary, Rana. You were talking about the EV, and it came to mind that it might not be over, right, for the number of ADCs we use in clinical practice in the near future. I mean, we've seen very promising data for ADC against the HER2, right, and over-expression. It also can create some challenges, right, in the clinics because we're asking to test for HER2 expression. It's almost like, it's not exactly the same to do it in breast cancer, but it looks one more time that we're a little bit behind the breast cancer field in a lot of angles. And also has vedotin as a payload. Of course, I'm referring to disitamab vedotin, and there's very elegant data described by you in your review chapter as well. And it's going to be very interesting to see how we sequence the different ADCs, to your point as well. So, before we wrap it up, I just want to give you the opportunity to tell us if there's any area that we have not touched, any take-home points you'd like to bring up for our listeners before we call it a day. Dr. Rana McKay: Thank you so much. I have to say, you know, I was so excited at ASCO this year looking at the GU program. It was fantastic to see the progress being made, novel therapeutics that really there's a tremendous excitement about, not just in RCC and in UC, but also in prostate cancer, thinking about the integration of therapies, not just for people with refractory disease that, even though our goal is to improve survival, our likelihood of cure is low, but also thinking about how do we integrate these therapies early in the treatment landscape to enhance cure rates for patients, which is just really spectacular. We're seeing many of these agents move into the perioperative setting or in combination with radiation for localized disease. And then the special symposium on biomarkers, I mean, we've really come a long, long way. And I think that we're going to continue to evolve over the next several years. I'm super excited about where the field is going in the treatment of genitourinary malignancies. Dr. Pedro Barata: Oh, absolutely true. And I would say within the Annual Meeting, we have outstanding Educational Sessions. And just a reminder to the listeners that actually that's where the different teams or topics for the Educational Book chapters come from, from actually the educational sessions from ASCO. And your fantastic chapter is an example of that, right, focusing on advanced GU tumors. So, thank you so much, Rana, for taking the time, sharing your insights with us today on the podcast. It was a fantastic conversation as always. Dr. Rana McKay: My pleasure. Thanks so much for having me, Dr. Barata. Dr. Pedro Barata: Of course.  And thank you to our listeners for your time today. You will find the link to the article discussed today in the transcript of this episode. I also encourage you to check out the 2025 ASCO Educational Book. You'll find an incredible wealth of information there. It's free, available online, and you'll find, hopefully, super, super important information on the key science and issues that are shaping modern oncology, as we've heard from Dr. McKay and many other outstanding authors. So, thank you, everyone, and I hope to see you soon. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:        Dr. Pedro Barata @PBarataMD Dr. Rana McKay @DrRanaMcKay Follow ASCO on social media:        @ASCO on X (formerly Twitter)        ASCO on Bluesky       ASCO on Facebook        ASCO on LinkedIn        Disclosures:     Dr. Pedro Barata: Stock and Other Ownership Interests: Luminate Medical Honoraria: UroToday Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck  Dr. Rana McKay: Consulting or Advisory Role: Janssen, Novartis, Tempus, Pfizer, Astellas Medivation, Dendreon, Bayer, Sanofi, Vividion, Calithera, Caris Life Sciences, Sorrento Therapeutics, AVEO, Seattle Genetics, Telix, Eli Lilly, Blue Earth Diagnostics, Ambrx, Sumitomo Pharma Oncology, Esiai, NeoMorph, Arcus Biosciences, Daiichi Sankyo, Exelixis, Bristol Myers Squibb, Merck, Astrazeneca, Myovant Research Funding (Inst.): Bayer, Tempus, AstraZeneca, Exelixis, Bristol Myers Squibb, Oncternal Therapeutics, Artera    

Are you living the same year over and over, or are you moving toward your vision? In this week's episode of The Genesis Frequency, we go deeper into the process of creating a powerful vision for your life — and uncovering the hidden paradigms that keep you stuck.Last week, we talked about clarifying your big dream goals and noticing what holds you back. This week, we'll look at why vision alone isn't enough. We'll talk about the subconscious programming — the paradigms — that quietly dictate your behavior and results. And most importantly, you'll discover why you can't break free on your own, and why having a skilled guide is the fastest, most effective way to transform your life and business.You'll hear wisdom from great teachers like Bob Proctor, Jack Canfield, Wayne Dyer, Ralph Waldo Emerson, and Michael Bernard Beckwith, reminding us that all things are possible when vision meets belief, action, and mentorship.This is your wake-up call. You don't have to stay stuck in cycles of self-sabotage. You can have your thriving business, your dream career, your ideal relationships — but you must act, and you must have guidance.Don't wait for another year to slip by. Tune in, take notes, and then take action. Your new beginning starts now.Produced by:Dr. Koz (and effect!)Dr. Stephen J. Kosmyna, Ph.D.The Genesis Frequency Podcast / Success Ocean International / LMI-USAPersonal, Professional and Leadership Development

A sermon for Ordinary Time from Rector Jon Odom, reflecting on Acts 2:37-47.

Emma G returns to Paradigms to share some fun easy useful tools for sparking inspiration.  Experience three creativity exercises, we'll also be listening to some  Emma G music! Emma G's new book Mental Health Sounds Like This has just become … More ... The post Emma G – Music, Creativity Tools, New Book “Mental Health Sounds Like This” appeared first on Paradigms Podcast.

Welcome to the latest episode of the Pre-Accident Investigation Podcast, hosted by Todd Conklin. In this engaging discussion, Todd chats with Jennifer Long about their unexpected journey in writing "Workers Are the Solution, Not the Problem: A Guidebook for Leading Differently." The conversation delves into the transformative insights they discovered about leadership, accountability, and how the evolving workforce requires fresh approaches. Throughout the episode, Todd and Jennifer explore how traditional views on leadership and workforce development are outdated, urging leaders to see workers as solutions rather than problems. They share their experiences and learning moments that shifted their paradigms and offer guidance for navigating the chaotic and unpredictable modern business environment. Join Todd and Jennifer as they reflect on their collaborative process and the critical lessons from their book, offering valuable perspectives for leaders aiming to adapt and thrive in today's dynamic world.

Recorded on Sunday July 27, 2025.We are back with another dispatch, this time discussing the effects of dialectics and paradigms that affect and help control discourse both domestically and internationally, including Palestine, particularly in the aftermath of October 7, as well as narratives around immigration crackdowns and raids. We also discuss personalities such as Alex Jones, Norman Finkelstein, and Ryan Dawson, and their roles in helping to shape these narratives

Dr Akila Viswanathan speaks with Dr Sophia Kamran from Harvard Medical School and Dr Constantinos Zamboglou from the German Oncology Center about the latest edition of Seminars in Radiation Oncology focusing on new treatments for advanced prostate cancer.

The Eyres start this episode talking about their family experience of building a log cabin in the Blue Mountains of Oregon; and then move into a discussion of the three false notions or "deceivers" of Control, Ownership and Independence. The conclude with the three replacement paradigms of Serendipity, Stewardship, and Synergicity. Find Happiness Paradox on Amazon, and join https://valuesparenting.com/how-to-live/.

Dr. Jeff Messer, holds a Ph.D. in exercise physiology and is one of the sharpest minds in distance coaching. He breaks down his science-backed approach to aerobic development, racing less, and building long-term success through consistency, not shortcuts.Listen now and learn why the process is the priority.

When it comes to your health and to your strength training, more specifically…Do you rely on social media trends or real science for your exercise routine? And how do you know if your workouts are actually safe and effective? Amy Hudson and Dr. James Fisher break down what “evidence-based strength training” really means, exposing common myths and highlighting why scientific research – and not old paradigms – should drive your fitness decisions. Hosts Amy Hudson and Dr. James Fisher unpack evidence-based strength training. Dr. Fisher believes that personal trainers should embrace an evidence-based approach, for the fact that people see them as part of the healthcare continuum, just like doctors, dentists, etc. Dr. Fisher explains what “evidence-based” actually means and what it entails. Remember: when it comes to strength training, there's a lot of misinformation on social media platforms. As Amy points out, hearing someone talk about the benefits they got by training a certain way doesn't automatically translate into you achieving the exact same result with the same workout. There are a variety of factors that could impact that, such as your varying ability levels, the metabolic competencies of your body, where you are with your joints, and more! Dr. Fisher touches upon the ACL reconstruction surgery he had and how that plays into the topic of evidence-based strength training. “Many institutions rely on evidence-based processes and on scientific research to drive their methodology forward. And strength training is no different at all,” says Dr. Fisher. Amy and Dr. Fisher talk about what evidence-based strength training actually looks like. Did you know that about 90% of exercising injuries are a product of free weight strength training? Training alone or having a supervised strength training session? According to some scientific evidence, supervision shows greater benefits in almost all facets of health, well-being, and physical adaptation compared to unsupervised workouts. The historic thinking and old paradigms that exist have been debunked by more recent science.  And that's really what evidence-based training is all about: being able to move with the scientific process. Interacting with coaches and asking them key questions is something Dr. Fisher believes anyone should do.     Mentioned in This Episode: The Exercise Coach - Get 2 Free Sessions! Submit your questions at StrengthChangesEverything.com Previous episode - Why Most People Fail in the Gym (And How Supervision With a Personal Trainer Can Help)     This podcast and blog are provided to you for entertainment and informational purposes only. By accessing either, you agree that neither constitute medical advice nor should they be substituted for professional medical advice or care. Use of this podcast or blog to treat any medical condition is strictly prohibited. Consult your physician for any medical condition you may be having. In no event will any podcast or blog hosts, guests, or contributors, Exercise Coach USA, LLC, Gymbot LLC, any subsidiaries or affiliates of same, or any of their respective directors, officers, employees, or agents, be responsible for any injury, loss, or damage to you or others due to any podcast or blog content.

Baruch Zeichner, host of the Paradigms Radio Show, discussed politics, including freedom, healthcare, and other topics, with Egberto Willies of Politics Done Right.Subscribe to our Newsletter:https://politicsdoneright.com/newsletterPurchase our Books: As I See It: https://amzn.to/3XpvW5o How To Make AmericaUtopia: https://amzn.to/3VKVFnG It's Worth It: https://amzn.to/3VFByXP Lose Weight And BeFit Now: https://amzn.to/3xiQK3K Tribulations of anAfro-Latino Caribbean man: https://amzn.to/4c09rbE

Amrita is a former Fortune 500 VP who has devoted 22+ years of her career to helping organizations thrive amid crises. Her work is dedicated to providing education and practical solutions for individuals and communities worldwide. Tell us about your personal experience of living through trauma and how it changed you? How can pain lead to growth? The pandemic is still largely under-processed. What makes you say that? Should we not move on? And denial is not a choice folks seem to be making. Do people want to process what they experienced during COVID? What were your research findings? Why do we need a two-way to process pain? How can and did pain lead to growth? Amrita Subramanian Amrita is a former Fortune 500 VP who has devoted 22+ years of her career to helping organizations thrive amid crises. Currently, she teaches at the University of Pennsylvania, focusing on posttraumatic growth through the pandemic, and has also almost completed her Ph.D on post-traumatic growth in adults through COVID-19. As the world faced COVID, the first collective trauma/crisis disruption in modern-day history, Amrita launched a first-of-its-kind study to explore how pain leads to growth and analyze our ability to heal ourselves during an unparalleled crisis. Her work is dedicated to providing education and practical solutions for individuals and communities worldwide. Her lessons draw from the evidence-based practices of everyday people who have shown heartfelt humility and wisdom in the face of crisis and devastation. The research study has amassed global participation, and she is convinced that it will show the pandemic strengthened us and renewed our sense of identity, purpose, and community. Amrita knows well that there is growth from trauma based on what she's endured in her own life. At the age of five, she was abandoned in a convent. The trauma and abuse she endured throughout that time resulted in selective mutism until she was 11 years old, among other things. Amrita is now using her voice to help guide humanity and speak out about the many facets of pain and what good could come from them. Excellent Executive Coaching Podcast If you have enjoyed this episode, subscribe to our podcast on iTunes. We would love for you to leave a review. The EEC podcasts are sponsored by MKB Excellent Executive Coaching that helps you get from where you are to where you want to be with customized leadership and coaching development programs. MKB Excellent Executive Coaching offers leadership development programs to generate action, learning, and change that is aligned with your authentic self and values. Transform your dreams into reality and invest in yourself by scheduling a discovery session with Dr. Katrina Burrus, MCC to reach your goals. Your host is Dr. Katrina Burrus, MCC, founder and general manager of Excellent Executive Coaching a company that specializes in leadership development.

NEW BOOK LINK YouTube video podcast link: https://linktr.ee/podcastandpoetrybookAarons Link:IG: @AaronMGambelTikTok: @AaronGambel Website: www.aarongambel.com5 Step Guide To Rewrite Your Story: www.aarongambel.com/rewite-your-story/

Stop Losing Quietly: Why Construction Needs a Massive Mindset Shift This isn't just another podcast this is a wake-up call for the construction industry. In this episode, Jason Schroeder tackles three brutally honest truths: Loyalty ≠ Career Growth: Why being “loyal” to a company isn't as noble as you think. The Super's Way is NOT the Right Way: Why letting people “do it their way” is killing progress and systems. CPM Isn't Strategy: If you're clinging to P6 and CPM as a shield, you might already be losing the war, just a little slower. Jason dives into what truly matters when choosing a company, why human behavior not systems is the biggest bottleneck in construction, and why we must stop defending broken processes. Whether you're a field engineer, a PM, or a company leader, this episode will challenge your thinking and push you to ask: Are we building to win or just trying to lose less? Listen now. Shift your mindset. Build better.   If you like the Elevate Construction podcast, please subscribe for free and you'll never miss an episode.  And if you really like the Elevate Construction podcast, I'd appreciate you telling a friend (Maybe even two

Aubrey converses with Prof Alison Kearney, an Associate Professor in the Faculty of Arts, Design and Architecture at the University of Johannesburg, about research that’s been doing in South African universities, whether is it be applied or not and how that can impact society. The Aubrey Masango Show is presented by late night radio broadcaster Aubrey Masango. Aubrey hosts in-depth interviews on controversial political issues and chats to experts offering life advice and guidance in areas of psychology, personal finance and more. All Aubrey’s interviews are podcasted for you to catch-up and listen. Thank you for listening to this podcast from The Aubrey Masango Show. Listen live on weekdays between 20:00 and 24:00 (SA Time) to The Aubrey Masango Show broadcast on 702 https://buff.ly/gk3y0Kj and on CapeTalk between 20:00 and 21:00 (SA Time) https://buff.ly/NnFM3Nk Find out more about the show here https://buff.ly/lzyKCv0 and get all the catch-up podcasts https://buff.ly/rT6znsn Subscribe to the 702 and CapeTalk Daily and Weekly Newsletters https://buff.ly/v5mfet Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

In this ep, we chat with Rodrigo Girão Serrão about his journey from mathematician to Pythonista. What started as a colleague's tip turned into 11 years of Python exploration. Rodrigo shares how his background in APL reshaped the way he writes Python, helping him embrace list comprehensions and functional patterns more intuitively.We dig into his latest side project—a bytecode compiler written in Python—and what that reveals about how Python really works under the hood. Rodrigo unpacks dunder methods, decorators, and how Python's consistent design makes building elegant, expressive code a joy.He also shares great advice on giving talks: from deep diving into topics to letting ideas evolve before structuring a presentation. His love for community and clarity in coding is contagious.Whether you're new to Python or a seasoned dev, this conversation will give you a deeper appreciation for the language we all love.Connect with Rodrigo on socials:Github: https://github.com/rodrigogiraoserraoLinkedIn: https://www.linkedin.com/in/rodrigo-gir%C3%A3o-serr%C3%A3o/Check our these links for some further reading/viewing:RP podcast: https://realpython.com/podcasts/rpp/252/The categorisation of the module itertools: https://mathspp.com/blog/module-itertools-overviewA tutorial on decorators: https://mathspp.com/blog/pydonts/decoratorsAn article about dunder methods: https://mathspp.com/blog/pydonts/dunder-methodsWhy APL is a language worth knowing (article): https://mathspp.com/blog/why-apl-is-a-language-worth-knowingHow APL made me a better Python developer (talk/video): https://www.youtube.com/watch?v=tDy-to9fgawThe series of articles with the compiler/interpreter: https://mathspp.com/blog/tags/bpciA tutorial is not a long talk: https://mathspp.com/blog/a-tutorial-is-not-a-long-talkHow I prepare a technical talk: https://mathspp.com/blog/how-i-prepare-a-technical-talk Structural pattern matching: https://peps.python.org/pep-0636/ ___

Join ASHRAE Journal Editor Drew Champlin as he interviews Max Sherman, Ph.D., Fellow/Life Member ASHRAE, about his award-winning article "IAQ Paradigms—The Next Generation.”  The conversation delves into the evolution of IAQ paradigms from ancient ventilation practices to modern standards, the role of ASHRAE in setting these standards, and the current paradigm shift focused on controlling infectious aerosols.

Equipping Hour | Gospel Paradigms | Unclean to Clean by OrlandoGrace

Equipping Hour | Gospel Paradigms | Poor to Rich by OrlandoGrace

3 Historical Paradigms: Experiential / Immediate / Prophecy vs. Cerebral / Unfolding/Law.

Qai from OS and David Erhan join me to continue our series refuting the Orientals. This is part 3. Orthodox Shahada is here  @OrthodoxShahada  Part 2: https://youtu.be/IurUmmCSLg4 Part 1: https://youtu.be/SHbyK2KoPfE Send Superchats at any time here: https://streamlabs.com/jaydyer/tip Join this channel to get access to perks: https://www.youtube.com/channel/UCnt7Iy8GlmdPwy_Tzyx93bA/join PRE-Order New Book Available in JULY here: https://jaysanalysis.com/product/esoteric-hollywood-3-sex-cults-apocalypse-in-films/ Get started with Bitcoin here: https://www.swanbitcoin.com/jaydyer/ The New Philosophy Course is here: https://marketplace.autonomyagora.com/philosophy101 Set up recurring Choq subscription with the discount code JAY44LIFE for 44% off now https://choq.com Lore coffee is here: https://www.patristicfaith.com/coffee/ Orders for the Red Book are here: https://jaysanalysis.com/product/the-red-book-essays-on-theology-philosophy-new-jay-dyer-book/ Subscribe to my site here: https://jaysanalysis.com/membership-account/membership-levels/ Follow me on R0kfin here: https://rokfin.com/jaydyer Music by Amid the Ruins 1453Become a supporter of this podcast: https://www.spreaker.com/podcast/jay-sanalysis--1423846/support.

Equipping Hour | Gospel Paradigms | Fear to Power by OrlandoGrace

Explaining how and why our world works the way it does touches on so many fields of science: biology, chemistry, physics, and, of course, technology. However, according to researcher Blaise Agüera y Arcas, computation should also be part of the understanding of life on all levels – and going back further than one might think. In What Is Life? Evolution as Computation, Agüera y Arcas uses computation as a means of examining the complexities of our own universe. Inspired by the work of quantum mechanics pioneer Erwin Schrödinger, he revisits the question that has showcased the divide between biology and physics: what is life? How can life and all its attendant complexities come to exist in a random universe, governed by simple laws, whose disorder only increases over time? What Is Life? aims to provide surprising answers, reframing core concepts of self-reproduction, complex growth, and symbiotic relationships as inherently computational. Agüera y Arcas draws on decades of theory and existing literature from figures like Alan Turing and John von Neumann, as well as recent endeavors in the field of artificial life. From evolution and symbiogenesis to thermodynamics and climate models, What Is Life? explores computation as a tool beyond raw calculation to understand intricate phenomena. This volume serves as a first installment of an ongoing body of work, with his larger book What Is Intelligence? further developing this perspective on intelligence from simple organisms to brains and from societies to AI. What Is Life? is richly illustrated and studded with examples, recontextualizing computational concepts and applications for a general audience curious about diving deeper into the machinations of our living world. Blaise Agüera y Arcas is a researcher and author focused on artificial intelligence, sociality, evolution, and software development. He is a VP and Fellow at Google, where he is the CTO of Technology & Society and founder of Paradigms of Intelligence (Pi). He is a frequent speaker at TED and has been featured in the Economist and Noēma, and has previously published the books Who Are We Now? and Ubi Sunt. Charles Tonderai Mudede is a Zimbabwean-born cultural critic, urbanist, filmmaker, college lecturer, and writer. He is the Senior Staff writer of the Stranger, a lecturer at Cornish College of the Arts, and has collaborated with the director Robinson Devor on three films, two of which Police Beat and Zoo, premiered at Sundance, and one of which, Zoo, screened at Cannes, and the most recent of which, Suburban Fury, premiered at New York Film Festival. (Police Beat is now part of MOMA's permanent collection.) Mudede, whose essays regularly appear in e-Flux and Tank Magazine, is also the director of Thin Skin (2023).

In today's episode, we spoke with Naval Daver, MD, about the evolving role of menin inhibition in acute myeloid leukemia (AML) and emerging data with revumenib (Revuforj) presented across ongoing clinical trials. Dr Daver is a professor in the Department of Leukemia and director of the Leukemia Research Alliance Program at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Brooke Passchier is a seasoned real estate professional, transformational coach, and founder of UnCaged Potential Coaching, where she empowers agents to grow both personally and professionally. With over a decade in real estate, Brooke has led a top-producing team, coached hundreds of agents across multiple offices, and developed a holistic coaching approach that blends business systems, mindset work, and spiritual growth. Her journey—marked by the challenges of single motherhood, financial hardship, and personal loss—has fueled her deep commitment to self-development and authenticity. Brooke believes that true business growth stems from inner transformation, and she is passionate about helping others unlock their uncaged potential through clarity, confidence, and conscious leadership.In our podcast, Brooke Passchier shares how real estate agents can ditch cold calling for good by aligning their business with authenticity and connection. We dive into the power of shifting your identity to unlock higher levels of production—without working harder—and how embracing inner growth leads to outer success. Brooke also reveals her strategies for preventing chaos in your business, creating systems and mindset habits that foster clarity, balance, and sustainable growth in both life and real estate..You Can Find Brooke@:Instagram: https://www.instagram.com/brookepasschier/Website: https://www.brookepasschier.com/

Dan Silberberg is a leadership visionary with a Fortune 500 track record, now focused on helping executives uncover the unconscious patterns that shape their leadership. In this powerful episode, Dan exposes the invisible operating system that drives our choices, beliefs, and leadership style, and why it's time to rewrite the code. If you're curious about how childhood beliefs, culture, and fear of standing out could be holding you back, this episode is your wake-up call. Experience our episodes in a whole new way and watch every video version on our YouTube channel HERE. Subscribe now to be the first to catch our next release. Soundbites [1:01] What does it mean to unmask leadership and uncover your true self? [3:45] How early childhood experiences shape unconscious beliefs about safety. [6:18] The link between Maslow's hierarchy and the hidden mindset of survival. [8:32] The default system formed through family, culture, religion, and school. [10:11] How children internalize blame and form lifelong narratives. [12:09] Why nurture is more powerful than nature in forming your worldview. [14:16] Experience vs. fact: most people confuse one for the other. [15:52] Why we play to fit in: survival instincts and tribal fear. [17:03] Why self-reflection alone isn't enough - you need mirrors like coaches. [18:20] How repetition hardwires your beliefs and keeps you small. [19:47] Paradigms reinforced by confirmation bias and group identity. [21:00] How we sabotage ourselves by staying in the comfort zone. [22:15] The impact of family patterns, religious institutions, and peer conformity. [24:01] Why leaders must confront unconscious behaviors to evolve. [25:48] Why younger leaders under 50 are more open to deep change. [27:04] Navigating five generations in the workforce and their value shifts. [28:19] Why self-awareness and purpose are the new leadership differentiators. [30:08] Reprogramming your unconscious mind in the present moment. [31:42] Beliefs about money: how early scripts sabotage adult success. [34:03] Why people rise, fall, and repeat success based on hidden paradigms. [35:45] Imposter syndrome - why it only afflicts successful people. [37:12] How past trauma shapes invisibility and fear of speaking up. [39:08] When your work is great but your voice is missing - what that reveals. [41:00] The real reason some C-suite leaders stay silent in the room. CONTACT DAN https://entelechy.ai/product/leader-council/⁠ ⁠https://entelechy.ai/contact/⁠ ⁠https://pages.c-suitenetwork.com/the-leader-council ABOUT PODCAST HOST, NINA SUNDAY To learn more about face-to-face training programs with Nina Sunday or one of her experienced Facilitators from Brainpower Training Pty Ltd in Australia Pacific, visit: ⁠⁠⁠⁠https://www.brainpowertraining.com.au/signature-programs/⁠⁠⁠⁠ To visit Nina Sunday's speaker site for global in-person speaking bookings visit: ⁠⁠⁠⁠https://www.ninasunday.com/⁠⁠⁠⁠ Connect with Nina Sunday on LinkedIn HERE: ⁠⁠⁠⁠https://www.linkedin.com/in/ninasunday/ ⁠⁠⁠⁠ To subscribe to Nina Sunday's personal blog go to ⁠⁠⁠⁠https://www.brainpowertraining.com.au/⁠ ⁠⁠⁠and scroll to bottom of the page to register. Learn more about your ad choices. Visit megaphone.fm/adchoices

Equipping Hour | Gospel Paradigms | Guilt to Righteousness by OrlandoGrace

Eid ul Adha | Stanford University | 6/6/25

In this wide-ranging conversation, we explore the implications of planetary-scale computation with Benjamin Bratton, Director of the Antikythera program at the Berggruen Institute and Professor at UC San Diego. Benjamin describes his interdisciplinary work as appearing like a "platypus" to others—an odd creature combining seemingly incompatible parts that somehow works as a coherent whole.At the heart of our discussion is Benjamin's framework for understanding how computational technology literally evolves, not metaphorically but through the same mechanisms that drive biological evolution: scaffolding, symbiogenesis, niche construction, and what he calls "allopoiesis"—the process by which organisms transform their external environment to capture more energy and information.Key themes we explore:Computational Evolution: How artificial computation has become the primary mechanism for human "allopoietic virtuosity"—our ability to reshape our environment to sustain larger populationsThe Embodiment Question: Moving beyond anthropomorphic assumptions about AI embodiment to imagine synthetic intelligence with radically different spatial capabilities and sensory arrangementsAgentic Multiplication: How the explosion of AI agents (potentially reaching hundreds of billions) will fundamentally alter human agency and subjectivity, creating "parasocial relationships with ourselves"Planetary Intelligence: Understanding Earth itself as having evolved a computational sensory layer through satellites, fiber optic networks, and distributed sensing systemsThe Paradox of Intelligence: Whether complex intelligence is ultimately evolutionarily adaptive, given that our computational enlightenment has revealed our own role in potentially destroying the substrate we depend onBenjamin challenges us to think beyond conventional categories of life, intelligence, and technology, arguing that these distinctions are converging into something more fundamental. As he puts it: "Agency precedes subjectivity"—we've been transforming our world at terraforming scales long before we were conscious of doing so.The conversation culminates in what Benjamin calls "the paradox of intelligence": What are the preconditions necessary to ensure that complex intelligence remains evolutionarily adaptive rather than self-destructive? As he notes, we became aware of our terraforming-scale agency precisely at the moment we discovered it might be destroying the substrate we depend on. It's a question that becomes increasingly urgent as we stand at the threshold of what could be either a viable planetary civilization or civilizational collapse—what Benjamin sees as requiring us to fundamentally rethink "what planetary scale computation is for."About Benjamin Bratton: Benjamin Bratton is a philosopher of technology, Professor of Philosophy of Technology and Speculative Design at UC San Diego, and Director of Antikythera, a think tank researching planetary computation at the Berggruen Institute. Beginning in 2024, he also serves as Visiting Faculty Researcher at Google's Paradigms of Intelligence group, conducting fundamental research on the artificialization of intelligence.His influential book The Stack: On Software and Sovereignty (MIT Press, 2015) develops a comprehensive framework for understanding planetary computation through six modular layers: Earth, Cloud, City, Address, Interface, and User. Other recent works include Accept All Cookies (Berggruen Press), written in conjunction with his co-curation of "The Next Earth: Computation, Crisis, Cosmology" at the 2025 Venice Architecture Biennale, and The Terraforming (Strelka), a manifesto arguing for embracing anthropogenic artificiality to compose a planet sustaining diverse life.

Are you a grandparent raising neurodivergent grandchildren, striving to navigate an unfamiliar world with compassion and confidence? Do you seek expert insights and practical strategies tailored for mentoring your unique family members? In a time where understanding neurodiversity is crucial, it can feel daunting to walk this path without guidance.I'm Laura Brazan, here to welcome you to 'Grandparents Raising Grandchildren: Nurturing Through Adversity.' Join us for an enlightening episode featuring Dr. Deborah Heiser, an applied developmental psychologist and founder of the Mentor Project. Together, we dedicate ourselves to educating, empowering, and equipping grandparents with confidence in mentoring. Discover how mentorship, driven by empathy and informed by expertise, can leave a transformational legacy for your grandchildren.Explore how to connect meaningfully with neurodivergent youth, cultivating their self-esteem and navigating their unique learning styles. Learn from real-life success stories and discover the power of supportive, inclusive mentorship. This is your invitation to stand strong in community, enhancing the future for your family—one informed decision at a time.Visit "The Mentor Project" for more information on Dr. Deborah Heiser, the project and her new fascinating book, "The Mentorship Edge".Send us a textVisit our homepage link to be informed and stay updated on our Pliot Program partnership with EggMed, an international health and mental wellness software design company. Do you ever feel like you can never do enough? If this is you, you've got to listen to this fun self-care tip from Jeanette Yates!Thank you for tuning into today's episode. It's been a journey of shared stories, insights, and invaluable advice from the heart of a community that knows the beauty and challenges of raising grandchildren. Your presence and engagement mean the world to us and to grandparents everywhere stepping up in ways they never imagined. Remember, you're not alone on this journey. For more resources, support, and stories, visit our website and follow us on our social media channels. If today's episode moved you, consider sharing it with someone who might find comfort and connection in our shared experiences. We look forward to bringing more stories and expert advice your way next week. Until then, take care of yourselves and each other.Want to be a guest on Grandparents Raising Grandchildren: Nurturing Through Adversity? Send Laura Brazan a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/grgLiked this episode? Share it and tag us on Facebook @GrandparentsRaisingGrandchilden Love the show? Leave a review and let us know! CONNECT WITH US: Website | Facebook

Equipping Hour | Gospel Paradigms | Shame to Honor by OrlandoGrace

On today's Bible Answer Man broadcast (05/28/25), Hank speaks about how attempts to read modern scientific paradigms into Scriptural passages have given Christians one black eye after another.Hank also answers the following questions:Can God be in the presence of evil, as in the case of God speaking to Satan concerning Job? What is your opinion of God having counsel with angels in Job 2? Pam - Due West, SC (5:49)A friend recently passed away. He believed in God, but his deployment to Iraq changed him. Now that he is gone, is it okay to pray for God to have mercy upon his soul? Derek - Kansas City, MO (8:47)I believe homosexuality is a sin, but I take issue with how vehemently Christians are against homosexuality. Why do we treat it differently than other sins? John - Salt Lake City, UT (15:10)If what we believe determines how we live, how is it that there are atheists who live generally moral lives while denying the existence of God? Kevin - Wichita, KS (19:04)

This week Carter and Nathan read Donella Meadows' Thinking in Systems. A foundational primer on systems thinking, the book explores how stocks, flows, feedback loops, and leverage points shape everything from ecosystems to organizations. Join them as they discuss how systems thinking applies to software engineering, the hidden structures behind burnout and tech debt, and how to make high-leverage changes in complex systems.-- Books Mentioned in this Episode --Note: As an Amazon Associate, we earn from qualifying purchases.----------------------------------------------------------Thinking in Systems by Donella H. Meadows https://amzn.to/4cMB35k (paid link)Tidy First?: A Personal Exercise in Empirical Software Design by Kent Beck https://amzn.to/3RoB9pR (paid link)Refactoring: Improving the Design of Existing Code by Martin Fowlerhttps://amzn.to/43Wqk5Q (paid link)Fundamentals of Software Architecture: An Engineering Approach by Mark Richards and Neal Fordhttps://amzn.to/3Y7CNjk (paid link)One Nation Under Blackmail, Vol. 1: The Sordid Union Between Intelligence and Crime that Gave Rise to Jeffrey Epstein by Whitney Alyse Webbhttps://amzn.to/3RsMt4f (paid link)Slow Productivity: The Lost Art of Accomplishment Without Burnout by Cal Newporthttps://amzn.to/3EH8MAe (paid link)The Software Engineer's Guidebook: Navigating Senior, Tech Lead, and Staff Engineer Positions at Tech Companies and Startups by Gergely Oroszhttps://amzn.to/3ExwPSa (paid link)What Is ChatGPT Doing ... and Why Does It Work? by Stephen Wolfram https://amzn.to/4iuSUim (paid link)----------------00:00 Intro 01:41 About the Book03:43 Thoughts on the Book08:07 Covering the Foundations and Defining Terms16:36 Feedback loops22:31 Overconfidence and why models lead us astray.35:56 Paradigms and Framing49:30 Leverage Points01:02:04 Final Thoughts----------------Spotify: https://open.spotify.com/show/5kj6DLCEWR5nHShlSYJI5LApple Podcasts: https://podcasts.apple.com/us/podcast/book-overflow/id1745257325X: https://x.com/bookoverflowpodCarter on X: https://x.com/cartermorganNathan's Functionally Imperative: www.functionallyimperative.com----------------Book Overflow is a podcast for software engineers, by software engineers dedicated to improving our craft by reading the best technical books in the world. Join Carter Morgan and Nathan Toups as they read and discuss a new technical book each week!The full book schedule and links to every major podcast player can be found at https://www.bookoverflow.io

Dahlia Dumont The Blue Dahlia returns to Paradigms to share her latest project Fantasia, and to talk about her life and what we're experiencing in the world these days. Dahlia was raised in New York and has been living in … More ... The post Dahlia Dumont – “Fantasia” appeared first on Paradigms Podcast.

Vanessa Sinclair, PsyD is a psychoanalyst in private practice, who works remotely online with people all over the world. She hosts the internationally-renowned podcast Rendering Unconscious, which was awarded the Gradiva Award for Digital Media by the National Association for the Advancement of Psychoanalysis (NAAP).Dr. Sinclair is the author of Things Happen (2024), Scansion in Psychoanalysis and Art: The Cut in Creation (2021), The Pathways of the Heart (2021), and Switching Mirrors (2016).She is the editor of Psychoanalytic Perspectives on the Films of Ingmar Bergman: From Freud to Lacan and Beyond(2023), as well as the Rendering Unconscious: Psychoanalytic Perspectives book series.Dr. Sinclair co-edited The Queerness of Psychoanalysis: From Freud and Lacan to Laplanche and Beyond (2025) with Elisabeth Punzi and Myriam Sauer, as well as Outsider Inpatient: Reflections on Art as Therapy (2021) with Elisabeth Punzi, On Psychoanalysis and Violence: Contemporary Lacanian Perspectives (2019) with Manya Steinkoler, and The Fenris Wolf vol 9 (2017) and The Fenris Wolf vol 11 (2022) with Carl Abrahamsson. She is a founding member of Das Unbehagen: A Free Association for Psychoanalysis, sits on the International Advisory Board for the journal Psychoanalysis, Culture & Society, and is Editorial Advisor for Parapraxis Magazine.Vanessa and I talk about her upcoming course with Morbid Anatomy, “The Cut in Creation: Exploring the Avant-Garde, Dada, Surrealism, Modern Art, Noise Music, and Performance Art through a Psychoanalytic Lens.” This course will be taking place on Sundays, from May 25- June 15, and all classes will be recorded for those who can't make it to the live class for whatever reason.As the Morbid Anatomy website states: Drawing on the theories of a variety of psychoanalysts, including Freud, Lacan and Laplanche, the course will explore the long and rich relationship between psychoanalysis and the fine arts – from painting and music to poetry, collage, photography, film, and performance art, including the use of technology and body modification to explore aspects of identity, gender and sexuality. Through immersion in the work of these artists and psychoanalytic ideas, participants will walk away with a better understanding of the transformative process inherent of the act of creation itself, especially when used as a powerful disruption of narrative, and hopefully feel inspired themselves to create! In this discussion, Vanessa gives a sneak peek into each of the four parts of the course. Some highlights are: talking about the inspiration for the course;outlining the events that led to the creation of psychoanalysis as well as the avant-garde movement;expanding on the historical backdrop – what was happening during these years that created this paradigm shift;looking at the years leading up to WW1, and what was taking place then, focusing on psychoanalysis and the avant-garde art scenes;focusing on surrealism and later developments in experimental film, followed by some discussion on the Beat Poets, and outlining how these three are interconnected;focusing on the birth of pop art, and art as it moved from the galleries to the streets, as well as performance art that included the body as an important vehicle/tool of expression. PROGRAM NOTES:Vanessa's website (with all links): Dr Vanessa SinclairMorbid Anatomy Course:The Cut in Creation: Exploring the Avant-Garde, Dada, Surrealism, Modern Art, Noise Music, and Performance Art through a Psychoanalytic Lens, Led by Vanessa Sinclair, PsyD, Begins May 25 — Morbid AnatomySelected Works:Amazon.com: Scansion in Psychoanalysis and Art (Art, Creativity, and Psychoanalysis Book Series): 9780367567262: Sinclair, Vanessa: BooksAmazon.com: The Queerness of Psychoanalysis: 9781032603827: Sinclair, Vanessa, Punzi, Elisabeth, Sauer, Myriam: BooksPodcast Rendering Unconscious:Podcast – Dr Vanessa SinclairInstagram:InstagramRobert Frank, Me and My Brother (1968)Me and My Brother (1968) - IMDbMusic, Editing and Video Production: Stephanie Shea

Welcome to a special installment of the Lectern Q&A! This month's theme is Love as a Virtue and Existential Stance. This session dives into the nature of love—not just as a feeling, but as a participatory, person-making virtue that binds us to reality and each other. Joining John and Ethan is Ellie, who brings both a deeply reflective presence and insightful contributions to this exploration. Lectern Q&As are a monthly gathering where John and Ethan take questions from The Lectern's members, threading through important themes that are most pertinent and perplexing to the collective. Pre-submitted questions form the bulk of the discussion with a Live Q&A segment toward the end. These conversations are particularly important for generating knowledge that is relevant both to John and The Lectern's broader audience. To participate in these discussions live, submit questions ahead of time and gain access to previous Q&As by signing up at the Alpha Tier (and above) on The Lectern: https://lectern.teachable.com/p/lectern-lounge If you would like to donate purely out of goodwill to support John's work, please consider joining our Patreon. https://www.patreon.com/johnvervaeke The Vervaeke Foundation is committed to advancing the scientific pursuit of wisdom and creating a significant impact on the world. https://vervaekefoundation.org/ If you would like to learn and engage regularly in practices that are informed, developed, and endorsed by John and his work, visit Awaken to Meaning's calendar to explore practices that enhance your virtues and foster deeper connections with reality and relationships. https://awakentomeaning.com/join-practice/ Chapter Timestamps 00:00 Welcome and Opening Reflections on Love 02:45 Love as an Existential Stance 05:00 Love, Participatory Knowing, and Binding Identity 08:45 Eros, Philia, and Agape: The Three Movements of Love 13:00 The Person-Making Nature of Love 17:00 Love as a Doorway to the Sacred 20:30 The Transformation of Self Through Love 23:45 Somatic and Embodied Knowing of Love 28:00 Trauma, Attachment, and the Challenge of Loving Well 32:10 Secure Attachment and Love as Practice 37:40 Circling, Dialectic, and Learning to Love Wisely 40:15 The Role of Worldview in Love and Meaning 46:50 A GI, the Sacred, and What We Truly Love About Humanity 54:20 The Ecology of Religions and Participatory Pluralism 59:30 Final Reflections from John, Ethan, and Ellie Biographical Sentences John Vervaeke is a cognitive scientist, philosopher, and the creator of the YouTube series Awakening from the Meaning Crisis. His work focuses on wisdom cultivation, consciousness, and the scientific pursuit of meaning. Ethan is a co-host and facilitator of the Lectern Q&A sessions. He curates conversations that illuminate existential, psychological, and philosophical insights emerging from the community and John's teachings. Ellie is a scholar and practitioner deeply engaged in environmental science, interpersonal growth, and attachment theory. She brings a reflective, embodied perspective to the conversation on love. Ideas, People, and Works Mentioned in this Episode Søren Kierkegaard John Bowlby, Attachment Theory Sue Johnson, Hold Me Tight, Attachment Theory in Practice Eric Fromm, The Art of Loving Thomas Kuhn, Paradigms and Worldview Albert Camus, The Stranger Martin Buber, I and Thou Taoism and the concept of the Dao as Mother Mahayana Buddhism, Bodhisattva path Sufism and Divine Love Socratic Knowledge and Dialogos Circling & Dialectic into Dialogos Lauren Barrett, Emotionally Focused Therapy Halcyon Guild Pluralism in religion and spiritual practice Connect with John Vervaeke Website: https://johnvervaeke.com/ Twitter: https://twitter.com/vervaeke_john YouTube: https://www.youtube.com/@johnvervaeke Patreon: https://www.patreon.com/johnvervaeke Thank you for Listening!

A Regnum Christi Daily Meditation. Sign up to receive the text in your email daily at RegnumChristi.com

Send us a textToday we discuss common paradigms and mindsets around rest and renewal.  We hope this helps us become aware of how we approach rest and expand how we engage.Support the show

As the first quarter closes, are you sprinting into Q2—or stumbling? In this timely freestyle episode of Leadership Is Changing, Denis urges us to “pause with purpose” and lean into the transformative power of the 3 Rs: Reflect, Reset, and Relaunch. Through personal anecdotes and leadership coaching insights, Denis shares a refreshingly simple framework that helps high performers regroup and reclaim their momentum. Whether Q1 was a triumph or a trial, this episode gives you the tools and mindset to take deliberate, consistent action toward success.If you're ready to clear mental clutter, reassess your habits, and design your next chapter with intention, this episode is your call to action.Slow Down to Go FasterThe year is flying—time to take a moment to breathe and recalibrateIntroduces the core idea: pausing with purpose is not a setback but a setup for accelerationMomentum or misstep, your Q1 outcome doesn't dictate the rest of your yearMake room for strategic thinking before jumping into the next quarterPen, Paper, and the Power of SketchbooksUse a blank sketchbook to get thoughts out of your head and onto paperHandwriting—not typing—creates stronger cognitive connectionsWriting frees up mental bandwidth and sharpens focusClarity comes from deliberate, messy, honest self-expressionReflect: The First RAsk yourself: What went well? What could I have done differently? What will I do going forward?Reflection reveals hidden growth opportunities and exposes outdated habitsSuccess leaves clues—your Q1 experience is full of themBob Proctor's legacy: Paradigms shape outcomes; paradigms are built from habitsReset: Energize Through Aligned GoalsReevaluate goals that feel heavy—replace them with ones that energize youRevise or refresh goals to fit your current momentum and focusIdentify new habits that will power your next stageReminder: “If your habits don't change, it won't be a new year—just another year”Relaunch: Act Boldly, Not PerfectlyDon't wait for perfection—massive action trumps meticulous planningLet your ideas sit, then return with fresh eyes to fine-tuneTrack your progress with weekly reviews or accountability check-insBuild momentum with deliberate action and mental readinessYour Turn: Take the First StepYour next chapter begins with reflection, not reactionBook a 30-minute clarity call with Denis if you need supportDo the internal work before reaching out—come prepared with your 3 RsSuccess is about what you do consistently, not occasionallyKey Quotes: ”If your habits don't change, you won't have a new year. You'll just have another year. “ - Denis Gianoutsos"Your next chapter is waiting—pause, reflect, reset, and relaunch." - Denis GianoutsosBook a Strategy Call with Denis https://app.leadingchangepartners.com/widget/bookings/callwithdenisgianoutsos The 10 Proven Ways to Lead and Thrive in Today's World Executive Guide Featuring 10 Key Themes and 42 Strategic Insights from Worldwide Leaders

Send us a textWhat drives someone to build a full-sized airplane in their basement? The same thing that makes us question insurance company CEOs, contemplate multiverses, or find reasons to stay alive during our darkest moments – the search for meaning.From the moment we descend into Dylan's basement workshop, surrounded by airplane parts and half-finished projects, this episode takes us on a journey through the things we build to outlast ourselves. Dylan's four-seater aircraft isn't just a hobby; it's a legacy he hopes his grandchildren will inherit (though he jokes they might use it to end his family line). This ambitious project, planned for completion in 2026, becomes a metaphor for purpose throughout our conversation.We pivot to discuss the recent shooting of a United Healthcare CEO, noting the strangely muted public reaction compared to other violent events. Digging deeper, we explore how the insurance industry's high denial rates (United's exceeds 30%) and massive profit margins have created a system where essential care becomes a business decision. This leads us to question how regulated industries often lack the competitive pressures that might otherwise force better practices.The most profound moments come when we share personal insights about mental health and suicide prevention. Referencing philosopher Albert Camus, we contemplate his assertion that deciding whether life is worth living is the only serious philosophical problem. What emerges is a surprisingly hopeful perspective: perhaps if we could see our lives as our own sitcoms – free from others' expectations and judgments – we might find more reasons to stick around and see what happens next.Whether you're building an airplane, questioning corporate ethics, or simply trying to find your purpose, this episode offers raw, unfiltered perspective on what makes a life worth living. Join us as we navigate these complex territories with humor, vulnerability, and occasional detours into carpeting ceilings and fitted sheet frustrations.

In this episode, we dive deep with Dr. John Lieurance, a pioneer in health innovations and founder of mitozen.com. We explore his groundbreaking work with methylene blue and melatonin, detailing their benefits beyond traditional uses. Dr. John shares his personal health struggles, highlighting his journey to discovering powerful therapies for conditions like mold toxicity, Lyme disease, and traumatic brain injuries. We also discuss the significance of parasympathetic nervous system activation and the role of melatonin in overall health. Additionally, Dr. John introduces his advanced clinic in Sarasota, Florida, and innovative treatments using regenerative medicine and stem cell therapy. Tune in to learn about cutting-edge health practices and why supplements like methylene blue and high-dose melatonin could revolutionize your well-being.   Connect with Dr. John here: Instagram Mitozen All Books Discover More   Our Sponsors: With Happy Hippo, you're getting a product that's been sterilized of pathogens, tested for impurities and heavy metals, and sold with a guarantee. Go to happyhippo.com/kkp and use Code KKP for 15% off the entire store If there's ONE MINERAL you should be worried about not getting enough of... it's MAGNESIUM. Head to http://www.bioptimizers.com/kingsbu now and use code KINGSBU10 to claim your 10% discount. Ready to elevate your health? Visit OneEarthHealth.com and use code: KKP at checkout for 10% off, or find us on Amazon. Remember, with One Earth Health, it's not just a supplement, it's a lifestyle. Tune in to nature, tune in to health. One Earth Health - Pure, Potent, Perfect." This Spring Fast Growing Trees have the best deals, for your yard, up to half off on select plants and other deals. And listeners to our show get FIFTEEN PERCENT OFF their first purchase when using the code KKP at checkout.  http://fastgrowingtrees.com/kkp   Connect with Kyle: I'm back on Instagram, come say hey @kylekingsbu Twitter: @kingsbu Fit For Service Academy App: Fit For Service App Our Farm Initiative: @gardenersofeden.earth Odysee: odysee.com/@KyleKingsburypod Youtube: Kyle Kingbury Podcast Kyle's Website: www.kingsbu.com - Gardeners of Eden site   If you enjoyed this podcast, please subscribe & leave a 5-star review with your thoughts!

As we embark on the final week of Women's History Month, social justice organizer, DEI expert and author of “Kindred Creation: Parables and Paradigms for Freedom,” Aida Mariam Davis talks about the importance of Black women's history, equal pay day, and if a new strategy is needed to protect women's lives. Become a supporter of this podcast: https://www.spreaker.com/podcast/tavis-smiley--6286410/support.

*This is the Free Content version of my interview with Dr. Liana Saif. To access the entire episode, please consider visiting www.patreon/RejectedReligion and become a Tier 1 'The Gates of Argonath' member, or you can purchase this episode for a one-time fee. The Patreon page offers much more content as well, including a book club that meets 4 times per year via Zoom. If you are interested in esoteric topics, please check it out!  ~ Many thanks, StephanieIn 2021, Liana Saif joined the Centre for the Study of Hermetic Philosophy and Related Currents at the University of Amsterdam as Assistant Professor in the History of Esotericism in the Middle Ages. Liana's work focuses on Islamic esotericism and the occult sciences, with a special interest in the exchange of esoteric and occult knowledge between the Islamic and Latin inhabited lands. Her book The Arabic Influences on Early Modern Occult Philosophy was published by Palgrave Macmillan in 2015. She is currently preparing a long-awaited critical translation from Arabic into English of the grimoire known as the Picatrix. A few of her research projects include the tenth-century secret brotherhood known as The Brethren of Purity, and the pseudo-Aristotelian Hermetica. She also worked as a project curator at the British Museum, deepening her interest in the material and artistic manifestations of the occult and the esoteric.Liana is a founding member of the European Network for the Study of Islam and Esotericism (ENSIE). Editorial roles include being a board member for Aries: Journal for the Study of Western Esotericism and Brill's Islamic Translation Series, and an associate editor of the journal Early Science and Medicine.In this interview, Liana speaks at length about Islamic Esotericism. This is an area of esoteric history that I haven't yet touched upon, so I was happy that Liana agreed to share her extensive knowledge on this topic. Some highlights of our discussion include: why the views and discourse of Islam within the area of “Western” esotericism is problematic; academic debates and disagreements in this area, how Liana defines Islamic esotericism, including paradigms and social orientations; and why the relationship between the idea of an eternal truth and the Islamic law raises anxiety in how Islamic esotericism is interpreted. Liana also discusses her research that deals with the 17th century Maltese inquisition, in particular the trial of Sellem the Moor, a Muslim enslaved person who was accused of being a magician. This work is part of a larger volume called Magic in Malta, and Liana examines this trial on three interconnected levels, and is a down-to-earth, practical example of how magic was being used by people at this time. Be sure to check out the program notes for links to all of the articles discussed in this episode. I hope you enjoy! PROGRAM NOTESLiana Saif | University of Amsterdam - Academia.edu"What is Islamic Esotericism", Correspondences, Vol. 7, issue 1 (2019)The Past and Future of the Study of Islamic EsotericismMagic and Divination Lost in Translation: A Cairene in a Maltese InquisitionA Preliminary Study of the Pseudo-Aristotelian Hermetica: Texts, Context, and DoctrinesResearch: Dr. Liana Saif - HHP | History of Hermetic Philosophy and related currentsAll Music and Editing: Daniel P. SheaEnd Production: Stephanie Shea

Wellness + Wisdom | Episode 711 Wellness + Wisdom Podcast Host, Josh Trent, joins Brett Ender and Harry McKeever on the Meat Mafia Podcast where he opens up about his struggles with old paradigms: breaking free from porn addiction and being overweight, what it means for him to live an embodied life filled with resilience, self-honesty, and faith, and how practices like the BTFA loop have shaped his new reality. What You'll Learn In This Episode [00:00] Josh's Journey Back Up After Hitting Rock Bottom Josh's background: 9.5 years of podcasting experience At age 21, Josh was 280 pounds, unhappy, and struggling with porn addiction Josh's weight loss journey: Lost 100 pounds in 3-6 months Emotional epigenetics and inherited trauma [11:35] Mental Health Struggles + Addiction Mindset Josh's struggle with pornography addiction from age 13 The normalization and weaponization of pornography in society Josh's realization of porn addiction at age 37 during an Ayahuasca journey The importance of honesty and sharing in overcoming addiction [22:40] Personal Growth + Spirituality Josh's spiritual journey only began at age 35 The concept of "who's doing it anyway" in relation to personal growth The importance of asking God for guidance and being humble to learn The BTFA (Belief, Thought, Feeling, Action) loop concept [34:25] Physical Health + Daily Practices for Wellness Josh's focus on emotional regulation for optimal performance The importance of contrast therapy: hot sauna and cold plunge Walking, free motion exercises, and body weight exercises How to listen to your body for exercise needs [44:35] Nutrition + Health The Whole30 program's recent stance on seed oils The importance of eating meat and listening to body cravings The need for seasonal eating and following ancestral wisdom [53:50] Politics + Health Freedom The recent election results and their potential impact on health policies The need for physical education in schools The influence of big pharma and food industries on health policies [01:04:40] Societal Changes + Future Outlook 2025 is a year of major revelations and changes The potential for RFK Jr.'s involvement in dismantling pharma influence The need for health freedom and making America healthy again [01:14:15] The Value of Truth The importance of speaking one's truth despite potential consequences The need for honesty in personal growth and societal change A "quantum leap forward" in terms of societal awareness and change [01:25:05] Living an Honest Life The importance of honesty and emotional regulation The challenges and rewards of living an honest life The need for fun and authenticity in conversations About Meat Mafia Podcast The Meat Mafia Podcast is all about shaking up the way we think about food, health, and how we live. Hosted by Brett Ender and Harry McKeever, the show dives deep into topics like regenerative farming, ancestral eating, metabolic health, and the messy truths about our food system. Brett and Harry bring a fresh, no-nonsense vibe to every conversation, mixing humor, curiosity, and practical advice as they unpack what it really takes to live a healthy, authentic life. Each episode features fascinating guests—from health experts and ranchers to entrepreneurs and advocates—sharing their personal stories and insights. Whether it's diving into the benefits of a carnivore or keto diet, exploring sustainable farming practices, or discussing the connection between mental and physical health, the podcast is packed with inspiration and ideas you can actually use. At its heart, the Meat Mafia Podcast is about building a community of people who are ready to take control of their health and rethink the way they live. If you're curious about what's possible when you step away from the mainstream and start living on your own terms, this podcast is for you. Instagram YouTube Spotify Leave Wellness + Wisdom a Review on Apple Podcasts Josh's Trusted Products | Up To 40% Off Shop All Products Biohacking⁠ MANNA Vitality - Save 20% with code JOSH20 HigherDOSE - 15% off with the code JOSH15 PLUNGE - $150 off with discount code WELLNESSFORCE Pulsetto - Save 20% with code "JOSH" SaunaSpace - 10% off with discount code JOSH10 Ultrahuman Ring Air - 10% off with code JOSH Wellness Test Kits Choose Joi - Save 50% on all Lab Tests with JOSH Blokes - Save 50% on all Lab Tests with JOSH FertilityWize Test by Clockwize - Save 10% with code JOSH Tiny Health Gut Tests - $20 off with discount code JOSH20 VIVOO Health Tests - Save 30% off with code JOSH SiPhox Health Blood Test - Save 15% off with code JOSH Nutrition + Gut Health Organifi - 20% off with discount code WELLNESSFORCE SEED Synbiotic - 25% off with the code 25JOSHTRENT Paleovalley - 15% off with the link only EQUIP Foods - 15% off with the code WELLNESS15 DRY FARM WINES - Get an extra bottle of Pure Natural Wine with your order for just 1¢ Just Thrive - 20% off with the code JOSH Legacy Cacao - Save 10% with JOSH when you order by the pound! Supplements MANNA GOLD - $20 off with the code JOSHGOLD Adapt Naturals - 15% off with discount code WELLNESSFORCE MitoZen - 10% off with the code WELLNESS FORCE Activation Products - 20% off with the code JOSH20 BiOptimizers - 10% off with discount code JOSH10 Fatty15 Essential Fatty Acids Supplement - Get 15% off with code JOSH15 Natural Energy MTE - Save 20% with JOSH TruKava - Save 20% with code JOSH20 Drink Update - Save 25% with discount code JOSH25 EONS Mushroom Coffee - 20% off with the discount code JOSH20 EnergyBITS - 20% off with the code WELLNESSFORCE BUBS Naturals - Save 20% with JOSH20 Fitness + Physical Health Detox Dudes Online Courses - Up to $500 off with discount code JOSH Kineon - 10% off with discount code JOSH10 Create Wellness Creatine Gummies - 20% off with discount code JOSH20 BioPro+ by BioProtein Technology - Save $30 OFF WITH CODE JOSH Drink LMNT - Zero Sugar Hydration: Get your free LMNT Sample Pack, with any purchase ⁠Myoxcience - 20% off with the code JOSH20 Healthy Home SunHome Saunas - Save $200 with JOSH200 JASPR Air Purifier - Save 10% with code WELLNESS QI-Shield EMF Device by NOA AON - 20% off with the code JOSH Zyppah Anti-Snoring Mouthpiece - 20% off with the code JOSH Holy Hydrogen - $100 off with discount code JOSH SimplyO3 - 10% off with discount code JOSH10 LEELA Quantum Upgrade + Frequency Bundles - Get 15 days free with code JOSH15 TrulyFree Toxic- Free Cleaning Products - Get 40% off + Freebies with code WELLNESSFORCE Mental Health + Stress Release Mendi.io - 20% off with the code JOSH20 Cured Nutrition CBD - 20% off with the discount code JOSH20 NOOTOPIA - 10% off with the discount code JOSH10 CalmiGo - $30 off the device with discount code JOSH30 QUALIA - 15% off with WELLNESSFORCE LiftMode - 10% off with JOSH10 Personal Care⁠ The Wellness Company's Emergency Health Kits + More - Save 10% with code JOSH Canopy Filtered Showerhead + Essential Oils - Save 15% with JOSH15 Farrow Life - Save 20% with JOSH Timeline Nutrition - 10% off with JOSH ⁠⁠Intelligence of Nature - 15% off Skin Support with the code JOSH15⁠⁠ Young Goose - Save 10% with code JOSH10 Mindfulness + Meditation BREATHE - 33% off with the code PODCAST33 Neuvana - 15% off with the code WELLNESSFORCE Essential Oil Wizardry - 10% off with the code WELLNESSFORCE Four Visions - Save 15% with code JOSH15 Lotuswei - 10% off with JOSH Clothing NativeToWear - Save 20% with code JOSH20 Rhizal Grounded Barefoot Shoes - Save 10% with code WELLNESS Earth Runners Shoes - 10% off with the code JOSHT10 MYNDOVR - 20% off with JOSH   Free Resources M21 Wellness Guide - Free 3-Week Breathwork Program with Josh Trent Join Wellness + Wisdom Community